Literature DB >> 26563887

Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults.

Ben Schöttker1, Kai-Uwe Saum2, Eugène H J M Jansen3, Bernd Holleczek4, Hermann Brenner5.   

Abstract

BACKGROUND: imbalances in metabolic, inflammatory and redox homeostasis play an important role in the leading theories of age-related morbidity, but no large-scale epidemiological study has been conducted so far assessing their associations with total morbidity and multi-morbidity in the same model.
METHODS: analyses were conducted in 2,547 participants of an established population-based cohort study from Germany. The participants' median age was 70 years (range: 57-84) and 51.9% were women. End points were total somatic morbidity and multi-morbidity, assessed by the Cumulative Illness Rating Scale-Geriatric version.
RESULTS: overall, 251 study participants had multi-morbidity (9.9%). Except for the redox marker 'total thiol levels of proteins', all other assessed metabolic (obesity, diabetes, dyslipidaemia and hypertension), inflammatory (C-reactive protein) and oxidative stress markers (derivatives of reactive oxygen metabolites) were significantly associated with total somatic morbidity and multi-morbidity if assessed individually. If modelled jointly, effect estimates were attenuated but remained statistically significant for the outcome 'total morbidity' and for low weight, obesity, insufficiently controlled diabetes and derivatives of reactive oxygen metabolites with respect to the outcome 'multi-morbidity'.
CONCLUSIONS: results from this large sample of older adults support hypotheses that relate imbalances in metabolic, inflammatory and redox homeostasis to age-related morbidity. Despite over adjustment for closely related metabolic, inflammatory and oxidative stress conditions in the full model, independent associations of the markers with total morbidity and/or multi-morbidity were observed. Therefore, adverse metabolic, inflammatory and oxidative stress conditions may all play important roles in the pathogenesis of age-related morbidity, which should be investigated further in future longitudinal studies.
© The Author 2015. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ageing; co-morbidity; inflammation; multi-morbidity; older people; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26563887     DOI: 10.1093/ageing/afv159

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  7 in total

1.  Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.

Authors:  Ben Schöttker; Kai-Uwe Saum; Dana Clarissa Muhlack; Liesa Katharina Hoppe; Bernd Holleczek; Hermann Brenner
Journal:  Eur J Clin Pharmacol       Date:  2017-05-24       Impact factor: 2.953

Review 2.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

3.  Oxidative stress in elderly population: A prevention screening study.

Authors:  Davide Gorni; Annarosa Finco
Journal:  Aging Med (Milton)       Date:  2020-08-09

4.  Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study.

Authors:  Arash Etemadi; Rashmi Sinha; Mary H Ward; Barry I Graubard; Maki Inoue-Choi; Sanford M Dawsey; Christian C Abnet
Journal:  BMJ       Date:  2017-05-09

5.  Prognostic stratification of older patients with multivessel coronary artery disease treated with percutaneous transluminal coronary angioplasty based on clinical and biochemical measures: protocol for a prospective cohort study.

Authors:  Ada Del Mar Carmona-Segovia; María Victoria Doncel-Abad; Víctor M Becerra-Muñoz; Jorge Rodríguez-Capitán; Fernando Sabatel-Pérez; María Flores-López; María José Sánchez-Quintero; Dina Medina-Vera; Ana Isabel Molina-Ramos; Rajaa El Bekay; José Miguel Morales-Asencio; María Angullo-Gómez; Luis García-Rodríguez; Lucía Palma-Martí; Francisco Javier Pavón-Morón; Manuel F Jiménez-Navarro
Journal:  BMJ Open       Date:  2022-02-28       Impact factor: 2.692

Review 6.  Normal and Pathological NRF2 Signalling in the Central Nervous System.

Authors:  Tony Heurtaux; David S Bouvier; Alexandre Benani; Sergio Helgueta Romero; Katrin B M Frauenknecht; Michel Mittelbronn; Lasse Sinkkonen
Journal:  Antioxidants (Basel)       Date:  2022-07-22

Review 7.  Physiological markers and multimorbidity: A systematic review.

Authors:  Gustavo Dias Ferreira; José Augusto Simões; Chamara Senaratna; Sanghamitra Pati; Pierre Fernando Timm; Sandro Rodrigues Batista; Bruno Pereira Nunes
Journal:  J Comorb       Date:  2018-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.